a KA
Generic Name: lopinavir/ritonavir
Pill imprint a KA has been identified as Kaletra 200 mg / 50 mg.
Kaletra is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy.
Kaletra 200 mg / 50 mg is not subject to the Controlled Substances Act.
See also related documents.
Kaletra Images
- Generic Name:
- lopinavir/ritonavir
- Imprint:
-
a KA
- Strength:
- 200 mg / 50 mg
- Color:
- Yellow
- Size:
- 19.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- copovidone
sorbitan monolaurate
silicon dioxide colloidal
sodium stearyl fumarate
titanium dioxide
polyethylene glycol 400
hydroxypropyl cellulose
magnesium silicate
polyethylene glycol 3350
ferric oxide yellow
polysorbate 80
hypromelloses
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Abbott Laboratories
- National Drug Code (NDC):
- 00074-6799
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-5752 | A S Medication Solutions LLC (repackager) |
| 54868-5566 | Physicians Total Care Inc (repackager) |
| 55045-3482 | Dispensing Solutions Inc. (repackager) |
| 55289-0947 | PDRX Pharmaceuticals Inc (repackager) |
| 00490-7028 | Southwood Pharmaceuticals Inc (repackager) |
| 35356-0112 | Lake Erie Medical and Surgical Supply (repackager) |
| 21695-0362 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Kaletra resources
- Kaletra
- Kaletra (Wolters Kluwer)
- Kaletra Capsules (Wolters Kluwer)
- Kaletra Solution (Wolters Kluwer)
- Kaletra (Cerner Multum)
- Kaletra (Micromedex) - Includes Dosage Information
- Kaletra (AHFS DI)
- Kaletra (FDA)
- Kaletra Oral Solution (FDA)
Search Again
